Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: Prognostic considerations

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 601-604

  Esposito, Vincenzo ^a,b   Baldi, Alfonso ^a   De Luca, Antonio ^a   Paciocco, Giuseppe ^b   Gröger, Angela ^c   Sgaramella, Giuseppe ^a   Claudio, Pier Paolo ^a   Giordano, Giovan Giacomo ^b   Baldi, Feliciano ^b   Caputi, Mario ^b   Kaiser, Hans ^d,e   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Mesothelioma; PCNA; Survival

Indexed keywords

CYCLINE;

ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; MESOTHELIUM; MESOTHELIUM CELL; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031043963     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bravo R, Frank R, Blundell P. MacDonald-Bravo H: Cyclin PCNA is the auxiliary protein of DNA polymerase delta. Nature 326: 515-517 1987.
2. Prelich G, Tan C, Kostura M: Functional identity of proliferating cell nuclear antigen and DNA polymerase delta auxiliary protein. Nature 326: 517-520, 1987.
3. Prelich G, Stillman B: Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53: 117-126, 1988.
4. Duronio RJ, O'Farrell PH: Developmental control of a G1-S transcriptional program in Drosophila. Development 120: 1503-1515 1994.
5. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication factor PCNA. Cell 71: 505-514, 1992.
6. Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R, Angeletti CA: The expression of proliferation cell nuclear antigen in paraffin sections of peripheral, node negative, NSCLC. Cancer 70: 1520-1527, 1992.
7. Hall PA, Levinson DA, Woods AL, Yu CW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with the evidence of deregulated expression in some neoplasms. J Pathol 62: 285-294, 1990.
8. Shonborn I, Zschiesche W, Minguillon C, Spitzer E, Mohner M, Ebeling K, Grosse R: Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopatological factors in breast cancer. J Canc Res Clin Oncol 121: 115-122, 1995.
9. Ramael M, Jacobs W, Wejler J, Van Meerbeck J, Bialasiewicz P, Van (De Bossche J, Buysse C, Vermeire P, Van Marck E: Proliferation in malignant mesothelioma determined by mitosis count and immunoreactivity for proliferating cell nuclear antigen (PCNA). J Pathol 172: 247-253, 1994.
10. Bethwaite PB, Delahunt B, Holloway Lj, Thornton A: Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma. Pathology 27: 1-4, 1995.
11. Koniecki J, Nugent P, Kordowska J, Baserga: Effect of the SV40 T antigen on the posttranscriptional regulation of the proliferating cell nuclear antigen and DNA polymerase-alpha genes. Cancer Res 51: 1465-1471, 1991.
12. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS, Procopio A: Simian Virus 40 -like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781-1790, 1994.